Vol. 21.C March - April 2021 | Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

•
Liver fibrosis in biliary atresia (BA) progresses within a short time.
•
A younger infant with BA could exhibit a higher grade of fibrosis.
•
Pathological findings in BA are well studied, but there are very few studies regarding temporal changes.
•
Bile ductular proliferation was the only independent feature showing temporal increase.

Open access

Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines

Jiaqi Yang, David Sontag, Yuewen Gong, Gerald Y. Minuk

Ann Hepatol. 2021;21C:265

Open access

The histone variant H3.3 regulates the transcription of the hepatitis B virus

Francisca Alvarez-Astudillo, Daniel Garrido, Manuel Varas-Godoy, José Leonardo Gutiérrez, Rodrigo A. Villanueva, Alejandra Loyola

Ann Hepatol. 2021;21C:261

Open access

Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases

Tomomi Kogiso, Takaomi Sagawa, Kazuhisa Kodama, Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige

Ann Hepatol. 2021;21C:260

Open access

miRNA-338-3p/CAMK IIα signaling pathway prevents acetaminophen-induced acute liver inflammation in vivo

Chen Zhang, Li Kang, Haihui Zhu, Jing Li, Rong Fang

Ann Hepatol. 2021;21C:191

Open access

Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission

Manuel Mendizabal, Federico Piñero, Ezequiel Ridruejo, Margarita Anders, María Dolores Silveyra, Aldo Torre, Pedro Montes, Alvaro Urzúa, ... Marcelo O Silva

Ann Hepatol. 2021;21C:100298

Open access

Open Article

Prognostic value of liver biochemical parameters for COVID-19 mortality

Lin Ye, Bin Chen, Yitong Wang, Yi Yang, Jiling Zeng, Guangtong Deng, Yuhao Deng, Furong Zeng

Ann Hepatol. 2021;21C:279

Open access

Open Article

Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19

Amer Hamadé, Bastien Woehl, Marjolaine Talbot, Naouel Bensalah, Pierre Michel, Golnaz Obringer, Michèle Lehn-Hogg, Nathalie Buschenrieder, ... Lucas Jambert

Ann Hepatol. 2021;21C:274

Open access

Open Article

Liver disease and outcomes among COVID-19 hospitalized patients – A systematic review and meta-analysis

Ashish Sharma, Pragya Jaiswal, Yasameen Kerakhan, Lakshmi Saravanan, Zeba Murtaza, Azka Zergham, Nagaraj-Sanchitha Honganur, Aelia Akbar, ... Preeti Malik

Ann Hepatol. 2021;21C:273

Open access

Open Article